FNYS
NVAX icon

First New York Securities’s Novavax NVAX Stock Holding History

First New York Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-550
Closed -$50K – 302
2014
Q1 		$50K Buy
+550
New +$61.4K 0.02% 257

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First New York Securities's NVAX Position: Q2 2014 in Review

First New York Securities sold out of Novavax (NVAX) in Q2 2014, closing a stake of 550 shares — an estimated $50K sold.

First New York Securities first reported a position in NVAX in Q1 2014 and held it in 1 quarter. The position peaked at $50K in Q1 2014. 137 funds tracked by Wall St. Rank hold NVAX as of Q2 2014.

  • First New York Securities reported no remaining Novavax position as of Q2 2014 after selling out during the quarter.
  • First New York Securities sold 550 Novavax shares in Q2 2014, an estimated $50K.
  • First New York Securities first reported a position in Novavax in Q1 2014 and held it in 1 quarter.
  • First New York Securities's Novavax position peaked at $50K in Q1 2014.
  • 137 funds tracked by Wall St. Rank held Novavax as of Q2 2014.

Based on First New York Securities's 13F filing for Q2 2014, filed 15 Aug 2014.